Potential pharmacological applications of polyphenolic derivatives from marine brown algae

Environmental Toxicology and Pharmacology

Volumn 32, Issue 3, 2011, Pages 325-335

  Thomas, Noel Vinay ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

Author keywords

Bioactive compounds; Brown algae; Laminariaceae; Phlorotannins

Indexed keywords

ACARBOSE; AGENTS AFFECTING CARBOHYDRATE METABOLISM; AHNFELTIOPSIS FLABELLIFORMIS EXTRACT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CAPTOPRIL; CYTOTOXIC AGENT; DIECKOL; DIOXINODEHYDROECKOL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHLORETHOHYDROXYCARMALOL; ECKLONIA CAVA EXTRACT; ECKLONIA STONIFERA EXTRACT; ECKOL; FUCOFUROECKOL A; LITHOPHYLLUM OKAMURAE EXTRACT; LOMENTARIA CATENATA EXTRACT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PHLOROFUCOFUROECKOL A; PHLOROGLUCINOL; PHLOROTANNIN DERIVATIVE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AHNFELTIOPSIS FLABELLIFORMIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BIOLOGICAL ACTIVITY; BROWN ALGA; DIABETES MELLITUS; DRUG MECHANISM; DRUG STRUCTURE; ECKLONIA CAVA; ECKLONIA STONIFERA; ENZYME INHIBITION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LITHOPHYLLUM OKAMURAE; LOMENTARIA CATENATA; MARINE SPECIES; MEDICINAL PLANT; NONHUMAN; PRECANCER; PRIORITY JOURNAL; REVIEW; SKIN TUMOR;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-HIV AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIHYPERTENSIVE AGENTS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ENZYME INHIBITORS; HUMANS; HYALURONOGLUCOSAMINIDASE; HYPOGLYCEMIC AGENTS; MATRIX METALLOPROTEINASES; PHAEOPHYTA; POLYPHENOLS; SEAWEED; TANNINS;

ALGAE; ECKLONIA; ECKLONIA CAVA; EISENIA ARBOREA; EISENIA BICYCLIS; LAMINARIACEAE; PHAEOPHYCEAE;

EID: 80054111600     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2011.09.004     Document Type: Review

References (95)

1. Actis-Goretta L., Ottaviani J., Fraga C. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J. Agric. Food Chem. 2006, 54:229-234.
2. Agar N., Halliday G., Barnetson R., Ananthaswamy H., Wheeler M., Jones A. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. PNAS 2004, 101:4954-4959.
3. Aggarwal B., Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 2006, 71:1397-1421.
4. Ahn G.N., Kim K.N., Cha S.H., Song C.B., Lee J., Heo M.S., Yeo I.K., Lee N.H., Jee Y.H., Kim J.S. Antioxidant activities of phlorotannins purified from Ecklonia cava on free radical scavenging using ESR and H2O2-mediated DNA damage. Eur. Food Res. Technol. 2007, 1:71-79.
5. Ahn M.J., Yoon K.D., Min S.Y., Lee J.S., Kim J.H., Kim T.G., Kim S.H., Kim N.G., Huh H., Kim J. Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava. Biol. Pharm. Bull. 2004, 27:544-547.
6. Ali M., Jahangir M., Saleem M., Pervez M., Hameed S., Ahmad V. Metabolites of marine algae collected from Karachi-coasts of Arabian sea. Nat. Prod. Sci. 2000, 6:61-65.
7. Apostolidis E., Lee C. In vitro potential of ascophyllum nodosum phenolic antioxidant mediated α-glucosidase and α-amylase inhibition. J. Food Sci. 2010, 75:97-102.
8. Arnold T.M., Targett N.M. Marine tannins: the importance of a mechanistic framework for predicting ecological roles. J. Chem. Ecol. 2002, 28:1919-1934.
9. Artan M., Li Y., Karadeniz F., Lee S.H., Kim M.M., Kim S.K. Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava. Bioorg. Med. Chem. Lett. 2008, 16:7921-7926.
10. Athukorala Y., Jeon Y. Screening for angiotensin 1-converting enzyme inhibitory activity of Ecklonia cava. J. Food Sci. Nutr. 2005, 10:134-139.
11. Athukorala Y., Kim K., Jeon Y. Antiproliferative and antioxidant properties of an enzymatic hydrolysate from brown alga, Ecklonia cava. Food Chem. Toxicol. 2006, 44:1065-1074.
12. Atkinson A., Robertson J. Captopril in the treatment of clinical hypertension and cardiac failure. Lancet 1979, 2:836-839.
13. Bhandari M., Jong-Anurakkun N., Hong G., Kawabata J α-Glucosidase and α-amylase inhibitory activities of Nepalese medicinal herb Pakhanbhed (Bergenia ciliata, Haw.). Food Chem. 2008, 106:247-252.
14. Caddeo C., Teskac K., Sinico C., Kristl J. Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int. J. Pharm. 2008, 363:183-191.
15. Cha S., Lee K., Jeon Y. Screening of extracts from red algae in Jeju for potentials marine angiotensin-I converting enzyme (ACE) inhibitory activity. Algae Inchon. 2006, 21:343-348.
16. Chakrabarti R., Rajagopalan R. Diabetes and insulin resistance associated disorders: disease and the therapy. Curr. Sci. 2002, 83:1533-1538.
17. Coussens L., Fingleton B., Matrisian L. Matrix metalloproteinase inhibitors and cancer - trials and tribulations. Science 2002, 295:2387-2392.
18. De Clercq E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med. Res. Rev. 2000, 20:323-349.
19. Fuchs J. Potentials and limitations of the natural antioxidants RRR-α-tocopherol, l-ascorbic acid and β-carotene in cutaneous photoprotection1. Free Radic. Biol. Med. 1998, 25:848-873.
20. Ha K.T., Kim J.K., Kang S.K., Kim D.W., Lee Y.C., Kim H.M., Kim C.H. Inhibitory effect of Sihoga-Yonggol-Moryo-Tang on matrix metalloproteinase-2 and -9 activities and invasiveness potential of hepatocellular carcinoma. Pharmacol. Res. 2004, 50:279-285.
21. Harada H., Kamei Y. Selective cytotoxicity of marine algae extracts to several human leukemic cell lines. Cytotechnology 1997, 25:213-219.
22. Haslam E., Cai Y. Plant polyphenols (vegetable tannins): gallic acid metabolism. Nat. Prod. Rep. 1994, 11:41-66.
23. Henry B.E., Van Alstyne K.L. Effects of UV radiation on growth and phlorotannins in Fucus gardneri (Phaeophyceae) juveniles and embryos. J. Phycol. 2004, 40:527-533.
24. Heo S.J., Hwang J.Y., Choi J.I., Han J.S., Kim H.J., Jeon Y.J. Diphlorethohydroxycarmalol isolated from Ishige okamurae, a brown algae, a potent α-glucosidase and α-amylase inhibitor, alleviates postprandial hyperglycemia in diabetic mice. Eur. J. Pharmacol. 2009, 615:252-256.
25. Heo S.J., Jeon Y.J. Radical scavenging capacity and cytoprotective effect of enzymatic digests of Ishige okamurae. J. Appl. Phycol. 2008, 20:1087-1095.
26. Heo S.J., Ko S.C., Cha S.H., Kang D.H., Park H.S., Choi Y.U., Kim D., Jung W.K., Jeon Y.J. Effect of phlorotannins isolated from Ecklonia cava on melanogenesis and their protective effect against photo-oxidative stress induced by UV-B radiation. Toxicol. In Vitro 2009, 23:1123-1130.
27. Heo S.J., Park P.J., Park E.J., Cho S.K., Kim S.K., Jeon Y.J. Antioxidative effect of proteolytic hydrolysates from Ecklonia cava on radical scavenging using ESR and H2O2-induced DNA damage. Food Sci. Biotechnol. 2005, 14:614-620.
28. Hollman P.C.H., Katan M.B. Dietary flavonoids: intake, health effects and bioavailability. Food Chem. Toxicol. 1999, 37:937-942.
29. Hwang H., Chen T., Nines R.G., Shin H.C., Stoner G.D. Photochemoprevention of UVB induced skin carcinogenesis in SKH 1 mice by brown algae polyphenols. Int. J. Cancer 2006, 119:2742-2749.
30. Iroyukifujita H., Eiichiyokoyama K., Yoshikawa M. Classification and antihypertensive activity of angiotensin i converting enzyme inhibitory peptides derived from food proteins. J. Food Sci. 2000, 65:564-569.
31. Iwai K. Antidiabetic and antioxidant effects of polyphenols in brown alga Ecklonia stolonifera in genetically diabetic KK-A y mice. Plant Foods Hum. Nutr. 2008, 63:163-169.
32. Jain R., Sonawane S., Mandrekar N. Marine life: new hope for cancer drugs. Indian J. Caner 2009, 46:243-244.
33. Joe M.J., Kim S.N., Choi H.Y., Shin W.S., Park G.M., Kang D.W., Kim Y.K. The inhibitory effects of eckol and dieckol from Ecklonia stolonifera on the expression of matrix metalloproteinase-1 in human dermal fibroblasts. Biol. Pharm. Bull. 2006, 29:1735-1739.
34. Jung H.A., Hyun S.K., Kim H.R., Choi J.S. Angiotensin converting enzyme I inhibitory activity of phlorotannins from Ecklonia stolonifera. Fisheries Sci. 2006, 72:1292-1299.
35. Jung H.A., Oh S.H., Choi J.S. Molecular docking studies of phlorotannins from Eisenia bicyclis with BACE1 inhibitory activity. Bioorg. Med. Chem. Lett. 2010, 20:3211-3215.
36. Jung H.A., Yoon N.Y., Woo M.H., Choi J.S. Inhibitory activities of extracts from several kinds of seaweeds and phlorotannins from the brown alga Ecklonia stolonifera on glucose-mediated protein damage and rat lens aldose reductase. Fisheries Sci. 2008, 74:1363-1365.
37. Kahl R. Synthetic antioxidants: biochemical actions and interference with radiation, toxic compounds, chemical mutagens and chemical carcinogens. Toxicology 1984, 33:185-228.
38. Kahl R., Kappus H. Toxicology of the synthetic antioxidants BHA and BHT in comparison with the natural antioxidant vitamin E. Z. Lebensm. Unters. Forsch. 1993, 196:329-338.
39. Kang C., Jin Y.B., Lee H., Cha M., Sohn E., Moon J., Park C., Chun S., Jung E.S., Hong J.S. Brown alga Ecklonia cava attenuates type 1 diabetes by activating AMPK and Akt signaling pathways. Food Chem. Toxicol. 2010, 48:509-516.
40. Kim M.M., Ta Q.V., Mendis E., Rajapakse N., Jung W.K., Byun H.G., Jeon Y.J., Kim S.K. Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity. Life Sci. 2006, 79:1436-1443.
41. Kim Y.C., An R.B., Yoon N.Y., Nam T.J., Choi J.S. Hepatoprotective constituents of the edible brown alga Ecklonia stolonifera on tacrine-induced cytotoxicity in hep G2 cells. Arch. Pharm. Res. 2005, 28:1376-1380.
42. King H., Aubert R., Herman W. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21:1414-1431.
43. Kojima T., Koike A., Yamamoto S., Kanemitsu T., Miwa M., Kamei H., Kondo T., Iwata T. Eisenin (l-pyroGlu-l-Gln-l-Ala), a new biological response modifier. J. Immunother. 1993, 13:36-42.
44. Kong C.S., Kim J.A., Yoon N.Y., Kim S.K. Induction of apoptosis by phloroglucinol derivative from Ecklonia cava in MCF-7 human breast cancer cells. Food Chem. Toxicol. 2009, 47:1653-1658.
45. Kousaka K., Ogi N., Akazawa Y., Fujieda M., Yamamoto Y., Takada Y., Kimura J. Novel oxylipin metabolites from the brown alga Eisenia bicyclis. J. Nat. Prod. 2003, 66:1318-1323.
46. Le Q.T., Li Y., Qian Z.J., Kim M.M., Kim S.K. Inhibitory effects of polyphenols isolated from marine alga Ecklonia cava on histamine release. Process Biochem. 2009, 44:168-176.
47. Lebovitz H.E. Alpha-glucosidase inhibitors. Endocrinol. Metab. Clin. 1997, 26:539-551.
48. Lee S.H., Karadeniz F., Kim M.M., Kim S.K α-Glucosidase and α-amylase inhibitory activities of phloroglucinal derivatives from edible marine brown alga, Ecklonia cava. J. Sci. Food Agric. 2009, 89:1552-1558.
49. Lee S.H., Qian Z.J., Kim S.K. A novel angiotensin I converting enzyme inhibitory peptide from tuna frame protein hydrolysate and its antihypertensive effect in spontaneously hypertensive rats. Food Chem. 2010, 118:96-102.
50. Lee S.H. Anti-inflammatory Mechanisms of Phlorotannins Derived from Eisenia bicyclis and Their inhibitory Effects on Matrix Metalloproteinases 2010, Pukyong National University, Busan, South Korea.
51. Li Y., Qian Z.J., Ryu B.M., Lee S.H., Kim M.M., Kim S.K. Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava. Bioorg. Med. Chem. Lett. 2009, 17:1963-1973.
52. Liu C., Li X., Li Y., Feng Y., Zhou S., Wang F. Structural characterisation and antimutagenic activity of a novel polysaccharide isolated from Sepiella maindroni ink. Food Chem. 2008, 110:807-813.
53. Mantena S., Meeran S., Elmets C., Katiyar S. Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors. J. Nutr. 2005, 135:2871-2877.
54. Matsui T., Tanaka T., Tamura S., Toshima A., Tamaya K., Miyata Y., Tanaka K., Matsumoto K α-Glucosidase inhibitory profile of catechins and theaflavins. J. Agric. Food Chem. 2007, 55:99-105.
55. Messina M., Persky V., Setchell K., Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 1994, 21:113-131.
56. Nelson A., Fingleton B., Rothenberg M., Matrisian L. Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 2000, 18:1135-1149.
57. Noel Vinay T., Se-Kwon K. Metalloproteinase inhibitors: status and scope from marine organisms. Biochem. Res. Int. 2010, 2010:10.
58. Novak N., Bieber T. Allergic and nonallergic forms of atopic diseases. J. Allergy Clin. Immunol. 2003, 112:252-262.
59. Okada Y., Ishimaru A., Suzuki R., Okuyama T. A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications. J. Nat. Prod. 2004, 67:103-105.
60. Pallela R., Yoon N.Y., Kim S.K. Anti-photoaging and photoprotective compounds derived from marine organisms. Mar. Drugs 2010, 8:1189-1208.
61. Pavia H., Cervin G., Lindgren A., Aberg P. Effects of UV-B radiation and simulated hebivory on phlorotannins in the brown alga Ascophyllum nodosum. MEPS 1997, 157:139-146.
62. Pavlaki M., Zucker S. Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials. Cancer Metast. Rev. 2003, 22:177-203.
63. Queiroz K.C.S., Medeiros V.P., Queiroz L.S., Abreu L.R.D., Rocha H.A.O., Ferreira C.V., Jucá M.B., Aoyama H., Leite E.L. Inhibition of reverse transcriptase activity of HIV by polysaccharides of brown algae. Biomed. Pharmacother. 2008, 62:303-307.
64. Ragan M.A., Glombitza K.W. Phlorotannins, brown algal polyphenols. Progress in Phycological Research 1986, 129-241. Cambridge University Press, Newyork. J.A. Hellebust, J.S. Craigie (Eds.).
65. Rajapakse N., Mendis E., Kim M.M., Kim S.K. Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells. Bioorg. Med. Chem. 2007, 15:4891-4896.
66. Ruberto G., Baratta M.T., Biondi D.M., Amico V. Antioxidant activity of extracts of the marine algal genus Cystoseira in a micellar model system. J. Appl. Phycol. 2001, 13:403-407.
67. Ryu B.M., Li Y., Qian Z.J., Kim M.M., Kim S.K. Differentiation of human osteosarcoma cells by isolated phlorotannins is subtly linked to COX-2, iNOS, MMPs, and MAPK signaling: implication for chronic articular disease. Chem. Biol. Interact. 2009, 179:192-201.
68. Ryu B.M., Qian Z.J., Kim M.M., Nam K.W., Kim S.K. Anti-photoaging activity and inhibition of matrix metalloproteinase (MMP) by marine red alga, Corallina pilulifera methanol extract. Radiat. Phys. Chem. 2009, 78:98-105.
69. Schaeffer D.J., Krylov V.S. Anti-HIV activity of extracts and compounds from algae and cyanobacteria. Ecotoxicol. Environ. Saf. 2000, 45:208-227.
70. Seo U.K., Lee Y.J., Kim J.K., Cha B.Y., Kim D.W., Nam K.S., Kim C.H. Large-scale and effective screening of Korean medicinal plants for inhibitory activity on matrix metalloproteinase-9. J. Ethnopharmacol. 2005, 97:101-106.
71. Sheinkopf L.E., Rafi A.W., Do L.A.T., Katz R.M., Klaustermeyer W.B. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study. Allergy Asthma Proc. 2008, 29:530-537.
72. Shibata T., Fujimoto K., Nagayama K., Yamaguchi K., Nakamura T. Inhibitory activity of brown algal phlorotannins against hyaluronidase. Int. J. Food Sci. Technol. 2002, 37:703-709.
73. Shibata T., Ishimaru K., Kawaguchi S., Yoshikawa H., Hama Y. Antioxidant activities of phlorotannins isolated from Japanese Laminariaceae. J. Appl. Phycol. 2008, 20:705-711.
74. Shibata T., Kawaguchi S., Hama Y., Inagaki M., Yamaguchi K., Nakamura T. Local and chemical distribution of phlorotannins in brown algae. J. Appl. Phycol. 2004, 16:291-296.
75. Shibata T., Nagayama K., Tanaka R., Yamaguchi K., Nakamura T. Inhibitory effects of brown algal phlorotannins on secretory phospholipase A2s, lipoxygenases and cyclooxygenases. J. Appl. Phycol. 2003, 15:61-66.
76. Shim S.Y., Quang T.L., Lee S.H., Kim S.K. Ecklonia cava extract suppresses the high-affinity IgE receptor, Fce{open}RI expression. Food Chem. Toxicol. 2009, 47:555-560.
77. Singh I., Bharate S. Phloroglucinol compounds of natural origin. Nat. Prod. Rep. 2006, 23:558-591.
78. Sugiura Y., Matsuda K., Okamoto T., Kakinuma M., Amano H. Anti allergic effects of the brown alga Eisenia arborea on Brown Norway rats. Fisheries Sci. 2008, 74:180-186.
79. Sugiura Y., Matsuda K., Yamada Y., Nishikawa M., Shioya K., Katsuzaki H., Imai K., Amano H. Isolation of a new anti-allergic phlorotannin, phlorofucofuroeckol-B, from an edible brown alga, Eisenia arborea. Biosci. Biotechnol. Biochem. 2006, 70:2807-2811.
80. Tengamnuay P., Pengrungruangwong K., Pheansri I., Likhitwitayawuid K. Artocarpus lakoocha heartwood extract as a novel cosmetic ingredient: evaluation of the in vitro anti tyrosinase and in vivo skin whitening activities. Int. J. Cosmet. Sci. 2006, 28:269-276.
81. Thiele J.J., Podda M., Packer L. Tropospheric ozone: an emerging environmental stress to skin. Biol. Chem. 1997, 378:1299-1305.
82. van de Laar F.A., Lucassen P.L., Akkermans R.P., van de Lisdonk E.H., Rutten G.E., van Weel C α-Glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care 2005, 28:154-163.
83. Welsch C.A., Lachance P.A., Wasserman B.P. Dietary phenolic compounds: inhibition of Na+-dependent d-glucose uptake in rat intestinal brush border membrane vesicles. J. Nutr. 1989, 119:1698-1704.
84. Whitaker D., Carlson G. Anti-Inflammation mechanism of extract from Eisenia bicyclis (Kjellman) setchell. J. Pharm. Sci. 1975, 64:1258-1259.
85. WHO, 2010a. Factsheet: Diabetes. World Health Organization, Geneva. (accessed October 2010). http://www.who.int/mediacentre/factsheets/fs312/en/index.html.
86. WHO, 2010b. HIV/AIDS. World Health Organization, Geneva (accessed November 2010). http://www.who.int/hiv/topics/universalaccess/en/index.html.
87. Wijesekara I., Yoon N.Y., Kim S.K. Phlorotannins from Ecklonia cava (Phaeophyceae): biological activities and potential health benefits. Biofactors 2010, 36:408-414.
88. Xie Z., Wang Y., Liu Y., Liu Y. Ultraviolet-B exposure induces photo-oxidative damage and subsequent repair strategies in a desert cyanobacterium Microcoleus vaginatus Gom. Eur. J. Soil Biol. 2009, 45:377-382.
89. Yang H., Zeng M., Dong S., Liu Z., Li R. Anti-proliferative activity of phlorotannin extracts from brown algae Laminaria japonica Aresch. Chin. J. Oceanol. Limnol. 2010, 28:122-130.
90. Yoon N.Y., Chung H.Y., Kim H.R., Choi J.S. Acetyl and butyrylcholinesterase inhibitory activities of sterols and phlorotannins from Ecklonia stolonifera. Fisheries Sci. 2008, 74:200-207.
91. Yoon N.Y., Kim H.R., Chung H.Y., Choi J.S. Anti-hyperlipidemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats. Arch. Pharm. Res. 2008, 31:1564-1571.
92. Yoon N.Y., Lee S.H., Li Y., Kim S.K. Phlorotannins from Ishige okamurae and their acetyl- and butyrylcholinesterase inhibitory effects. J. Funct. Foods 2009, 1:331-335.
93. Yuan Y.V., Walsh N.A. Antioxidant and antiproliferative activities of extracts from a variety of edible seaweeds. Food Chem. Toxicol. 2006, 44:1144-1150.
94. Zhang C., Kim S.K. Matrix metalloproteinase inhibitors (MMPIs) from marine natural products: the current situation and future prospects. Mar. Drugs 2009, 7:71-84.
95. Zhang Y., Lee E.T., Devereux R.B., Yeh J., Best L.G., Fabsitz R.R., Howard B.V. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 2006, 47:410-413.